{Reference Type}: Journal Article
{Title}: Evaluating breast biopsy practice and breast biopsy marker utilisation in the clinical setting.
{Author}: Radic R;Taylor DB;
{Journal}: J Med Imaging Radiat Oncol
{Volume}: 67
{Issue}: 1
{Year}: Feb 2023
{Factor}: 1.667
{DOI}: 10.1111/1754-9485.13451
{Abstract}: <B>BACKGROUND: </B>Breast Screen Australia and Breast Screen Aotearoa guidelines recommend breast biopsy marker (BBM) use in indicated patients. This study aims to evaluate breast biopsy practice and BBM utilisation by modality.<BR><B>METHODS: </B>An online survey was disseminated to radiologists who identified 'breast imaging' as their area of practice in the Royal Australian and New Zealand College of Radiologists (RANZCR) customer relationship management system. Survey questions addressed participant demographics and factors relating to BBM use.<BR><B>RESULTS: </B>Most respondents (72%) place between 1 and 4 BBMs per week. Almost all (99%) respondents perform ultrasound-guided biopsy of the breast or axillary nodes, with 85% performing stereotactic or tomosynthesis-guided breast biopsy and 27% performing MRI-guided breast biopsy. BBM utilisation differs by modality, with 97% respondents always placing a BBM post-MRI-guided breast biopsy, 50% always placing a BBM post-stereotactic-guided biopsy and 3% always placing a BBM post-ultrasound-guided breast biopsy.<BR><B>CONCLUSIONS: </B>Almost all radiologists perform breast biopsy using ultrasound, stereotactic/tomosynthesis or MRI guidance. BBM utilisation varies by modality, with 72% of respondents placing between 1 and 4 clips per week. Reasons for placing or not placing BBM aligned with prior studies. This is the first study to evaluate the number of breast biopsies performed by radiologists on a weekly or monthly basis, providing a useful platform for comparison in the local setting.